机构:[1]Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510405, Guangdong, P.R. China[2]Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, P.R. China深圳市中医院深圳医学信息中心[3]The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, P.R. China深圳市中医院深圳医学信息中心[4]The First Clinical School, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, P.R. China深圳市中医院深圳医学信息中心[5]Department of Anesthesiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, P.R. China深圳市中医院深圳医学信息中心
National Natural Science Foundation of China [grant number 81673922]; the Project of Educational
Commission of Guangdong Province of China [grant number 20192A010002]; and the National Natural Science Youth
Foundation of China [grant number 81704167 (to Y.W.)].
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|3 区生物
小类|4 区生化与分子生物学4 区细胞生物学
最新[2025]版:
大类|3 区生物学
小类|3 区生化与分子生物学4 区细胞生物学
第一作者:
第一作者机构:[1]Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510405, Guangdong, P.R. China
通讯作者:
推荐引用方式(GB/T 7714):
Zhang Xiong,Li Yongxing,Wang Yong,et al.Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.[J].Bioscience reports.2020,40(5):doi:10.1042/BSR20194030.
APA:
Zhang Xiong,Li Yongxing,Wang Yong,Zhuang Yuerong,Ren Xiaojie...&Zhong Ming.(2020).Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis..Bioscience reports,40,(5)
MLA:
Zhang Xiong,et al."Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.".Bioscience reports 40..5(2020)